Mach7 Technologies Ltd
Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million, with a current market price of AUD 0.305 per share. The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and returns data are not available for Mach7 Technologies Ltd, as the valuation snapshot does not include metrics such as return on invested capital (ROIC) or operating margins. Without these metrics, a direct comparison to industry peers and medians cannot be made. The company's segments and geographic exposure are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification. Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Analysts have assigned a mean price target of AUD 0.62, with a median of AUD 0.62, indicating a potential upside from the current market price. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. The company is also flagged for potential liquidity risk, though the severity is not quantified. No dilution potential is indicated, as basic and diluted shares are equal. Recent events, such as filings or transcripts, are not disclosed in the available data, limiting insight into the company's recent strategic or operational developments.
Business. Mach7 Technologies Ltd provides healthcare equipment and technology solutions, primarily serving the healthcare services and equipment sector.
Classification. Mach7 Technologies Ltd is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a classification confidence of 0.92.
- Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million.
- The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares.
- Analysts have assigned a mean price target of AUD 0.62, suggesting potential upside from the current market price.
- Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
- The company's profitability and returns data are not available, making it difficult to compare with industry peers.
- # RATIONALES
- ```json
- {
- Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).